Media
27. November, 2020
Massiv interesse for børsnotering
Det nystiftede bioselskab Cessatech med en tidligere Lundbeck-direktør i spidsen og prominente folk i...
Releases
27. November, 2020
Cessatech’s IPO of units significantly oversubscribed
Subscribed to DKK 107 million, corresponding to a subscription ratio of approx. 680 percent....
Media
24. November, 2020
CESSATECH VILL BEDÖVA BARN VIA NÄSAN
STOCKHOLM (Nyhetsbyrån Direkt) Det danska forskningsbolaget Cessatech, som utvecklar behandlingar för barn, tänker ge...
Media
10. November, 2020
Cessatech mot börsen med nässpray mot smärta
Danska Cessatech har utvecklat en nässpray för smärtlindring speciellt anpassad för barn. Den ska...
Releases
6. November, 2020
Approval for IPO listing
Cessatech A/S today announces that Spotlight Stock Market’s listing committee has approved Cessatech’s application...
Facts
31. August, 2020
DR.dk focus
Kan give voldsomme bivirkninger, når børn og ældre får medicin, der ikke er godkendt til dem...
Releases
18. August, 2020
Strong profiles to the Board
The Board has a wide experience from the entire value chain, which is a strong asset for Cessatech and its future aspirations
Media
26. May, 2020
Copenhagen Science
Novel painkiller is remarkably close to market, and the team is now expanding its business development activities
Facts
1. May, 2020
High off-label use
Studies are still needed to determine the safety and efficacy of drugs that lack FDA labeling for this vulnerable patient population. Drugs were administered off-label...
Facts
1. May, 2020
Small adults?
Children differ pharmacokinetically from adults, and medication for adults cannot simply be administered in smaller doses
Media
14. December, 2019
TV2 Nyhederne
En nyudviklet næsespray, er dagens store nyhed i TV2 Nyhederne - udviklet på Rigshospitalet af ledende eksperter